In female mice with bead-injected eyes, daily Brinzolamide eye drops blunted but did not eliminate the cumulative intraocular pressure increase compared with bead injection alone. In SD rats, reduced-concentration Brinzolamide formulation Azopt administered to the right eye produced no observed ocular hypotensive effects. [2,3]
Brinzolamide and intraocular pressure following bead injection
Animal study · female C57BL/6 mice; bead-injected eyes [2]
Female C57BL/6 mice with bead-injected eyes received daily brinzolamide eye drops. Compared with bead injection alone, daily brinzolamide blunted but did not eliminate the cumulative IOP increase; mean daily IOP percentage increases were 20.0% ± 2.6% with brinzolamide and 26.9% ± 2.3% with bead injection alone.
Conditions shared by the study groups
- Route
- IOP-lowering eye drops
- Treatment course
- once per day for the duration of the experiment, including weekends; between 10 AM and 2 PM; 6-week study
- Brinzolamide brinzolamide 1%
- Model: female C57BL/6 mice; bead-injected eyes
- Reported limits: Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: Brinzolamide
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and Methods > Animals (S1); Materials and Methods > Intraocular Pressure Elevation (S4, S6, S8, S9); Results (S60, S61, S63); Figure 2 legend (S102)
mean daily IOP percentage increases (±SEM): mean daily IOP percentage increases (±SEM); comparator: only bead injection — Results (S60, S61)
Brinzolamide brinzolamide 1% · Materials and Methods > Intraocular Pressure Elevation (S8, S9); Results (S60, S61); Figure 2 legend (S102)
Brinzolamide and intraocular pressure in SD rats
Animal study · SD rats (10–12 weeks) [3]
In SD rats, reduced-concentration Brinzolamide formulation Azopt was administered to the right eye, with saline as the control. No ocular hypotensive effects were observed.
Conditions shared by the study groups
- Route
- administrated to the right eye
- Treatment course
- The IOPs of both eyes were measured under anaesthesia every hour for up to 6 h.
- Brinzolamide 0.2% Azopt (10 μL)
- Model: SD rats (10–12 weeks)
- Reported limits: Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: Brinzolamide; Compound label in the paper: Azopt
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results > Ocular hypotensive effects of brinzolamide prodrug nano eye-drops (S52); Methods > Evaluation of intraocular pressure (IOP) (S111, S112, S113, S114)
IOP: IOP; comparator: saline (10 μL) — Results > Ocular hypotensive effects of brinzolamide prodrug nano eye-drops (S52); Methods > Evaluation of intraocular pressure (IOP) (S112)
Brinzolamide 0.2% Azopt (10 μL) · Results > Ocular hypotensive effects of brinzolamide prodrug nano eye-drops (S52); Methods > Evaluation of intraocular pressure (IOP) (S113, S114)